A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 206 participants.
Also called NCT02554877
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 206 participants
- Sponsor
- Registry
-
NCT02554877
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT02554877. Randomized; double masking; primary purpose treatment. Start 2015-10 (registry gives no type); primary completion 2016-08 (actual). Results posted on 2017-08-07.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- PF-06291874
- Intervention (Drug)
- Placebo
- Lead sponsor
- Pfizer
Record details
- Record id
cardio:ct-nct02554877- Content hash
d8aae1a18f7b7158545faba0333ad15e209a75aaf53d5dff831d2b7c9037d52e